Global Health Developments: Key Insights and Updates
Current health news highlights a planned IPO by Medline Industries aiming to exceed $5 billion, a second Australian death from methanol poisoning in Laos, GSK's RSV vaccine approval in Japan, and McKinsey’s legal resolution related to the U.S. opioid crisis.
Medline Industries, a prominent medical supply company, intends to raise over $5 billion through an IPO by 2025, potentially valuing the firm at around $50 billion, sources revealed to Reuters. The timeline and details remain subject to prevailing market conditions.
In a tragic development, a second Australian citizen has passed away following methanol poisoning linked to tainted alcohol in Laos, which marks the sixth such fatality, confirmed authorities.
GSK's RSV vaccine received Japanese authorization for use among adults aged 50 to 59, expanding its reach as severe RSV risks grow for this demographic.
(With inputs from agencies.)
ALSO READ
China's Rare Earths Restrictions Impact Japanese Industries
Japan to explain stance on China's export controls in U.S. next week, finmin says
UPDATE 2-South Korea's President Lee to visit Japan for a summit with PM Takaichi
South Korea's President Lee to visit Japan January 13-14 for summit, Newsis reports
Japan’s Defense Dilemma: Rising Concerns Over China’s Military Ambitions
Google News